ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

Articles by Amit Sen GuptaSubscribe to Amit Sen Gupta

B K Keayla: A Personal Reminiscence

Bal Krishan Keayla, a key figure in the National Working Group on Patent Law and an indefatigable campaigner for two decades against the GATT/WTO agreement on intellectual property, died on 27 November. A colleague in the working group reminisces.

Lethal Dust

For the past few months, there has been growing evidence of the hazards posed to soldiers and citizens of war-afflicted zones by the use of depleted uranium in anti-tank weapons. Increased cases of cancer and other health disorders have been reported from Iraq and from the Balkans. It is now clear that the US was aware of the potential dangers of depleted uranium, but its efforts at cover-up are, however, under increasing international scrutiny.

Economic Reforms, Health and Pharmaceuticals-Conferring Legitimacy to the Market

Conferring Legitimacy to the Market Reforms in Health Care STRUCTURAL adjustment policies were introduced in this country in 1991 by the previous Congress government. These policies sought to by way of fiscal austerity measures cut government spending and subsidies in social sectors, reduce direct taxes, increase administered prices, liberalise trade by reducing tariff rates and providing other incentives for foreign investments, privatise public enterprises, deregulate the labour market, etc. The policies were designed to clear the path for withdrawal of the state from the social and welfare sectors like health, education, public distribution system, etc. These policies use 'free market' ideology as the guiding principle, and are designed to place the 'market' in a central position of dominance, where it would act as the principal, if not sole, arbitrator of all processes. At a global level such a position is extended to encompass the concept of 'free trade' a concept that has been captured in its full essence by the GATT treaty of

Do Drugs Cost Less in India

Amit Sen Gupta A comparative analysis of drug prices in India and other countries shows that the average cost of older drugs is highest in India, while newer pharmaceutical products still under patent protection globally, or recently out of its purview, are cheapest in India.

Back to Top